Literature DB >> 23388884

The impact of a change in hypertension management guidelines on diuretic use in Japan: trends in antihypertensive drug prescriptions from 2005 to 2011.

Takahide Kohro1, Tsutomu Yamazaki, Hiroki Sato, Kazuhiko Ohe, Ryozo Nagai.   

Abstract

The Japanese Society of Hypertension (JSH) updated its hypertension management guidelines in 2009. One of the most significant changes with respect to the 2004 version was the stance towards the use of diuretics: in 2004, their use was cautioned against, but in 2009, it was actively promoted. The purpose of this study was to measure the impact of this change in guidelines on prescription patterns for antihypertensive medications, and to investigate the overall trend in the use of antihypertensives. We used monthly claims data obtained from a database company. Data of patients who were 20 or more years old and prescribed antihypertensives were extracted and analyzed. There were 66 223 patients who were prescribed antihypertensives (mean age 53.6±11.0). Of these, 38 130 were men and 28 093 were women. The two most prescribed classes of antihypertensives were angiotensin receptor blockers, whose usage steadily increased over a 7-year period, and calcium channel blockers. Prescriptions for antihypertensives in these two classes were also more likely to be continued than those for other antihypertensive classes. The prescription rate for diuretics increased from December 2006 (P<0.0001), but the rate of increase was the same before and after 2009 (P=0.09). The clinical guidelines published in 2009 had no apparent impact on the trend of diuretic prescriptions, despite the radical change in stance concerning the use of antihypertensives. Further effort to disseminate the content of these guidelines, so that it is reflected in actual clinical practice, may be warranted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23388884     DOI: 10.1038/hr.2012.216

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  8 in total

1.  Safety and clinical outcome in combination therapy for high-risk elderly hypertensive patients.

Authors:  Seiji Umemoto
Journal:  Hypertens Res       Date:  2014-11-27       Impact factor: 3.872

2.  Current prescription status of antihypertensive drugs with special reference to the use of diuretics in Japan.

Authors:  Ai Ibaraki; Wataru Goto; Rie Iura; Mitsuhiro Tominaga; Takuya Tsuchihashi
Journal:  Hypertens Res       Date:  2016-09-01       Impact factor: 3.872

3.  Long-term effects of spironolactone in peritoneal dialysis patients.

Authors:  Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Hirofumi Tamai; Takeyuki Hiramatsu; Hiroshige Ohashi; Isao Ito; Hirotake Kasuga; Masanobu Horie; Shoichi Maruyama; Yukio Yuzawa; Tatsuaki Matsubara; Seiichi Matsuo
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

4.  Comprehensive Trends and Patterns of Antihypertensive Prescriptions Using a Nationwide Claims Database in Korea.

Authors:  Minji Jung; Eunjung Choo; Sukhyang Lee
Journal:  Clin Epidemiol       Date:  2020-09-11       Impact factor: 4.790

5.  A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update.

Authors:  Ryosuke Tateishi; Koji Uchino; Naoto Fujiwara; Tetsuo Takehara; Takeshi Okanoue; Masataka Seike; Hitoshi Yoshiji; Hiroshi Yatsuhashi; Masahito Shimizu; Takuji Torimura; Mitsuhiko Moriyama; Isao Sakaida; Hiroyuki Okada; Tetsuhiro Chiba; Makoto Chuma; Kazuhiko Nakao; Hajime Isomoto; Yutaka Sasaki; Shuichi Kaneko; Tsutomu Masaki; Kazuaki Chayama; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2018-11-29       Impact factor: 7.527

6.  Prescribing Patterns of Antihypertensives for Treatment-Naïve Patients in South Korea: From Korean NHISS Claim Data.

Authors:  Sang Hyuck Kim; Dong Wook Shin; Shinhye Kim; Kyungdo Han; Sang-Hyun Park; Yul-Hee Kim; Shin-Ae Jeon; Yong-Chol Kwon
Journal:  Int J Hypertens       Date:  2019-08-25       Impact factor: 2.420

7.  Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.

Authors:  Shinzo Hiroi; Yukio Shimasaki; Takashi Kikuchi; Yujiro Otsuka; Kosuke Iwasaki; Mitsuru Ohishi
Journal:  Hypertens Res       Date:  2016-07-28       Impact factor: 3.872

8.  Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in korea.

Authors:  Mi-Hyang Jung; Ju-Hee Lee; Chan Joo Lee; Jeong-Hun Shin; Si Hyuck Kang; Chang Hee Kwon; Dae-Hee Kim; Woo-Hyeun Kim; Hack Lyoung Kim; Hyue Mee Kim; In Jeong Cho; Iksung Cho; Jinseub Hwang; Soorack Ryu; Chaeyeong Kang; Hae-Young Lee; Wook-Jin Chung; Sang-Hyun Ihm; Kwang Il Kim; Eun Joo Cho; Il-Suk Sohn; Sungha Park; Jinho Shin; Sung Kee Ryu; Moo-Yong Rhee; Seok-Min Kang; Wook Bum Pyun; Myeong-Chan Cho; Ki-Chul Sung
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-25       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.